Insider · CIK 0001611468
Paul W. Hoelscher
Files at SGMT (Sagimet Biosciences Inc.). First filing -, latest -.
In brief
Paul W. Hoelscher files SEC Form 4 as director at SGMT (Sagimet Biosciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Paul W. Hoelscher has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | SGMT Sagimet Biosciences Inc. | AGrant or award Stock Option (Right to Buy)derivative | +39,567 | $0.00 | $0 | 39,567 | Jun 15, 2026 |
| Jun 9, 2025 | SGMT Sagimet Biosciences Inc. | AGrant or award Stock Option (Right to Buy)derivative | +32,250 | $0.00 | $0 | 32,250 | Jun 10, 2025 |
Questions about Paul W. Hoelscher
Answered from the filings on this page, as of the latest one.
Is Paul W. Hoelscher buying or selling?
Paul W. Hoelscher has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Paul W. Hoelscher's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul W. Hoelscher has 0.
Where does Paul W. Hoelscher file Form 4?
Paul W. Hoelscher has filed Form 4 at SGMT (Sagimet Biosciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.